Abstract

AbstractThe oxygen‐dependent nature and limited penetration capacity of visible light render the low efficiency of photodynamic therapy in hypoxic and deep‐seated tumors. Therefore, the development of oxygen‐free photoactivated chemotherapy (PACT) to generate cytotoxic reactive oxygen species by near‐IR (NIR) light‐cleavable photocages is in high demand. Here, an oxygen‐irrelevant PACT strategy based on NIR light‐triggered hydroxyl radicals (•OH) generation is developed for free‐radical nanotherapy. Blebbistatin‐loaded upconversion of mesoporous silica nanoparticles (UCSNs‐B) is established to facilitate the high loading efficiency of blebbistatin and implement the efficient transformation of NIR light into blue light for unprecedented direct photorelease of oxygen‐independent •OH. Under NIR laser irradiation, UCSNs‐B converted NIR light into blue light, thus enabling the photocleavage of blebbistatin to induce the burst of •OH. The •OH burst under NIR laser irradiation further induces cancer cell apoptosis and significant suppression of hypoxic tumors. In addition, the gadolinium ion (Gd3+)‐doped UCSNs‐B are used as contrast agents in magnetic resonance imaging to facilitate real‐time monitoring of the therapeutic processes. This study effectively demonstrates that the UCSNs‐B act as NIR light‐triggered photocages to facilitate oxygen‐irrelevant •OH bursts, thus providing insights into the development of efficient PACT nanoagents for cancer treatment.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.